PrevANZ: Phase IIb Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Trial of Vitamin D3 in Patients with a First Demyelinating Event.

Project: Research

Status	Active
Effective start/end date	5/12/18 → 31/12/20